Navigation Links
Urine is a Rich Source of Phosphorus

An Australian researcher has suggested that the looming global shortage of phosphorus can be dealt with by recycling urine.

Associate Professor Cynthia Mitchell of the Institute for Sustainable Futures at the University of Technology, Sydney (UTS) reckons that the world's deposits of phosphorus may finish in about 50 years. She believes that if 132 gallons (500 litres) of urine each person produces in a year is recycled, the danger of running out of phosphorus can be averted.

"Urine is the most concentrated source of phosphorus. At the moment we dilute that through our sewage system and send it out to the ocean," Discovery News quoted her as saying.

"In the industrialized world we must start moving to a resource-recovery approach rather than the current waste-treatment approach," she added.

Phosphorus is a key component in agricultural fertilizers and a lack of phosphorus would affect future soil quality and production, according to the background information in the report published in the journal.

Mitchell insists that the Government has failed to address the issue of recycling urine because of a "poo taboo".

She will call for a "revolution in sanitation" across Australia when she gives a public lecture at the university later this week. She is sure that the "revolution" will happen.

"It has to for the simple reason that we are going to run out of other concentrated forms of phosphorus in about 50 years," she said.

"We are going to need sources of fertilizer ... and the most concentrated, readily accessible source of phosphorus is us," she added.

The technology that allows urine to be separated in the home is already in use in Sweden, Mitchell stresses. Mitchell says that all new homes in the local council of Tanum are required to have urine-separation toilets.

According to her, the toilets are similar to flushing toile
'"/>




Page: 1 2

Related medicine news :

1. Urine Test for Kidney Cancer
2. A Urine Test Could Predict Rejection In Transplant Patients
3. Urine Test for Kidney Cancer
4. Simple Urine Test Can Help To Monitor Disfiguring Birthmarks
5. Premature Babies More Likely If Women Have Higher Protein Albumin In Urine
6. Pregnancy Complications Could Be Prevented With A Urine Test
7. Testing Your Health & Charging Your Mobile At One Go - Check Out The Urine Powered Batteries
8. Urine testing for telomerase enzyme for bladder cancer diagnosis
9. Colour Of Urine Can Reveal The Health Status Of The Patients
10. Cancer Causing Chemicals Found In Urine Of Babies Whose Parents Smoke
11. Urine Purification to Revolutionize Waste Water Management
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Urine Rich Source Phosphorus

(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...ted by scientists at Wageningen University, Nether...s Vitamin B6) can slow down the cognitive decline ... has been known to help in the brain development o...long time now. Due to this reason it is administer...
...iscovered the key molecule that gets over activate...sets way for the condition to be expressed. Huntin...stroys the ability of the person to think or move ...e may be depression, mood swings, forgetfulness, a...
...ly issued a warning regarding the consumption of L...y contain glyburide - a drug that could have serio...The warning from the FDA has come after they learn...consumer complaint which was followed up with test...
...e able to stop the geriatric population from falli...aintain their balance. The device is called Yaktra...hat conforms to the footwear and helps the people ...g a stable walk that will prevent falls. Research...
Other Medicine News:
(Date:9/3/2008)... Company to Discuss Phase 3 Plans with...ile Therapeutics, Inc.,announced today that it su...e development of the company,s new, innovative low... company refers to by its internal product,code AG...ccessfully met its,primary endpoint of ovulation s...
(Date:9/3/2008)... SB-509 to be Evaluated in Repeat-Dosing Study in ...ewswire-FirstCall/ -- Sangamo,BioSciences, Inc. (N...a Phase,2 clinical trial (SB-509-801) to evaluate ...ive, degenerative motor-neuron disease for which t...Sangamo,s drug, SB-509, is an injectable formulati...
(Date:9/2/2008)...PARIS, September 3 /-, - T...ecreased the Risk,of Stroke by 34% in Patients Wit...equately Treated by Antithrombotic Therapy, The r... ATHENA study,were presented today at the clinical...ardiology congress 2008, in Munich, Germany. Previ...
(Date:9/2/2008)...HARRISBURG, Pa., Sept. 2 /PRNewswire-USNewswire/ -...ild animals is underway in western,Pennsylvania, A...e oral rabies vaccination baiting program covers a...r, Crawford, Erie, Fayette, Greene,Indiana, Lawre...counties., "Controlling the spread of rabies in w...
Breaking Medicine Technology:Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Rabies Vaccination Program Underway in Western Pennsylvania 2DHHS Guidelines Support Use of Trofile 28TM 29 Assay Prior to CCR5 Inhibitor Use 1303 1DHHS Guidelines Support Use of Trofile 28TM 29 Assay Prior to CCR5 Inhibitor Use 1303 2DHHS Guidelines Support Use of Trofile 28TM 29 Assay Prior to CCR5 Inhibitor Use 1303 3DHHS Guidelines Support Use of Trofile 28TM 29 Assay Prior to CCR5 Inhibitor Use 1303 4DHHS Guidelines Support Use of Trofile 28TM 29 Assay Prior to CCR5 Inhibitor Use 1303 52007 Another Record Year in Terms of Sales and Earnings for Gerresheimer 2952 12007 Another Record Year in Terms of Sales and Earnings for Gerresheimer 2952 22007 Another Record Year in Terms of Sales and Earnings for Gerresheimer 2952 3Smart holograms help patients help themselves 2104 1Smart holograms help patients help themselves 2104 2American Academy of Dermatology Research Confirms Genetic Skin Barrier Defect Linked to Eczema 10816 1American Academy of Dermatology Research Confirms Genetic Skin Barrier Defect Linked to Eczema 10816 2American Academy of Dermatology Research Confirms Genetic Skin Barrier Defect Linked to Eczema 10816 3American Academy of Dermatology Research Confirms Genetic Skin Barrier Defect Linked to Eczema 10816 4
...2007 /PRNewswire-FirstCall/ -- Boston,Scientific C...ticle,in the Journal of of Cardiology (JACC) revie...es the Company,s second-generation,TAXUS(R) Libert...cle in the April 24 edition of JACC concluded that... of the TAXUS Liberte Stent,system compared to the...
...ata Presented at ASCO -, CHICAGO, June 04, 2007 /P...ay that Soliris(TM) (eculizumab), a new treatment ...loped by Alexion,Pharmaceuticals, Inc. , is effect...ory of aplastic anemia (AA) or myelodysplastic,syn...ood cell,destruction (hemolysis), decreased or eli...
Other Medicine Technology:Positive Results for Second-Generation Taxus Liberte Coronary Stent,System Highlighted in Journal of American College of Cardiology 2Positive Results for Second-Generation Taxus Liberte Coronary Stent,System Highlighted in Journal of American College of Cardiology 3Positive Results for Second-Generation Taxus Liberte Coronary Stent,System Highlighted in Journal of American College of Cardiology 4Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 2Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 3Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 4Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 5Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 6Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 7
FlexWear is a cross-linked hydrocolloid skin barrier that provides aggressive adherence and is designed for more than one day weartime.
Inquire
Protects the skin over extended wearing time from irritating discharge. Flextend skin barrier is the barrier of choice for urostomies and ileostomies. Security and confidence assured with internal no
Protects the skin over extended wearing time from irritating discharge. Flextend skin barrier is the barrier of choice for urostomies and ileostomies with the added benefit of it being discreet in bo
Medicine Products: